StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate → 8-[2-(2-Azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane

HRID 928580
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 928580
[CH:1]12[N:8]([C:9]3[C:10]4[C:32]([C:33]5[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=5)=[CH:31][S:30][C:11]=4[N:12]=[C:13]([O:15][CH:16]4[CH2:21][CH:20]5[CH2:22][CH:17]4[CH2:18][N:19]5C(OC(C)(C)C)=O)[N:14]=3)[CH:5]([CH2:6][CH2:7]1)[CH2:4][O:3][CH2:2]2>C(Cl)Cl.FC(F)(F)C(O)=O>[CH:20]12[CH2:22][CH:17]([CH:16]([O:15][C:13]3[N:14]=[C:9]([N:8]4[CH:1]5[CH2:7][CH2:6][CH:5]4[CH2:4][O:3][CH2:2]5)[C:10]4[C:32]([C:33]5[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=5)=[CH:31][S:30][C:11]=4[N:12]=3)[CH2:21]1)[CH2:18][NH:19]2
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 1

HCID 89579513Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate

Produkt 1

HCID 895799438-[2-(2-Azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octaneAusbeute 2,7 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6344DichloromethaneLösungsmittelHCID 6422
Trifluoroacetic acid
Lösungsmittel

Versuchsvorschrift

Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate (269 mg, 0.503 mmol) was dissolved in DCM (2 mL) and trifluoroacetic acid (2 mL). The mixture was stirred at room temperature for 2 hrs and then evaporated. The residue was dissolved in water (2 mL) and DCM (2 mL). Solid sodium bicarbonate was added to neutralize the remaining acid. The layers were separated and the aqueous was extracted with DCM (2×2 mL). The combined organic layers were evaporated to give a brown solid. This was purified by preparative HPLC (acidic method 1). Fractions containing the target compound (by LCMS) were combined and evaporated. The residue was dissolved in methanol and applied to an SCX cartridge (2 g, equilibrated with methanol). The cartridge was washed with methanol (2 column volumes) then 0.5 M ammonia in methanol (2 column volumes). The ammonia solution was evaporated to give 8-[2-(2-azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane as a white solid (6 mg). LCMS RT=3.16 min. M+1=435.

Aufarbeitung

  1. customevaporated
  2. dissolutionThe residue was dissolved in water (2 mL)
  3. additionSolid sodium bicarbonate was added
  4. customThe layers were separated
  5. extractionthe aqueous was extracted with DCM (2×2 mL)
  6. customThe combined organic layers were evaporated
  7. customto give a brown solid
  8. customThis was purified by preparative HPLC (acidic method 1)
  9. additionFractions containing the target compound (by LCMS)
  10. customevaporated
  11. dissolutionThe residue was dissolved in methanol
  12. washThe cartridge was washed with methanol (2 column volumes)
  13. customThe ammonia solution was evaporated

Quellen und Nachweise

ORD-Eintrag
ord-074e5b7f4d51400fb0cccd52cd3efb82
Quelldatensatz
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09290511B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion